Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/ACAD
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

ACADIA Pharmaceuticals Inc. (ACAD) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

ACADIA Pharmaceuticals (ACAD) trades at $19.58, down 0.81% amid mixed clinical trial results. The stock shows strong fundamentals with $1.07B revenue, 33.42% net margin, and attractive P/E of 8.81. Recent Phase 2 Alzheimer's psychosis data missed primary endpoints but showed promise for continued development. Technical indicators signal bearish momentum with oversold RSI conditions.
Outlook remains cautiously optimistic given strong profitability and analyst consensus target of $32.32 (65% upside). Key risks include clinical trial uncertainties and patent litigation investigations. Institutional ownership remains substantial with recent BlackRock and Alyeska purchases supporting long-term confidence.
Read full analysis

Key Stats

  • Market Cap
    $3.39B
  • Volume
    1,784,486
  • Sector
    Health
  • 52W High
    $30.57
  • 52W Low
    $19.65
  • Typical Hold Time
    77 Days
  • Enterprise Value
    $2.50B
  • Div Yield
    -
  • Trading Activity
    0% Sell | 100% Buy
$19.39
52W Low: $19.39
09 Oct 2026
52W High: $30.57
25 Aug 2026

Track ACADIA Pharmaceuticals Inc. (ACAD) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, ACADIA Pharmaceuticals Inc. has traded between a low of $19.39 and a high of $30.57, highlighting its annual price range. Buy and sell ACADIA Pharmaceuticals Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Most Recent News

Content is generated by Aura AI

Sisecam showcases energy-efficient glass solutions at GlassBuild America, expanding U.S. market presence.

Sisecam, a global leader in glass production, participated in the GlassBuild America trade show in Las Vegas, presenting advanced architectural glass solutions tailored to the U.S. market. The company highlighted its energy-efficient, sustainable, an...

Market News
20 minutes ago
Na
Bullish
news icon
Sisecam showcases energy-efficient glass solutions at GlassBuild America, expanding U.S. market presence.

Class action lawsuit filed against The Ensign Group over alleged elder neglect and fraud claims.

The Rosen Law Firm has filed a class action lawsuit on behalf of investors who purchased The Ensign Group securities between February 2022 and June 2026. The lawsuit alleges that Ensign systematically neglected elderly residents in its care facilitie...

Market News
4 hours ago
GlobeNewsWire
Bearish
news icon
Class action lawsuit filed against The Ensign Group over alleged elder neglect and fraud claims.

Copa Holdings reports 17.1% rise in passenger traffic and 15.7% capacity increase in Sept 2026

Copa Holdings announced preliminary passenger traffic data for September 2026, showing a 17.1% increase in revenue passenger miles (RPM) to 2,674.4 million and a 15.7% rise in available seat miles (ASM) to 3,041.0 million compared to September 2025. ...

Market News
4 hours ago
Na
Bullish
news icon
Copa Holdings reports 17.1% rise in passenger traffic and 15.7% capacity increase in Sept 2026
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $3.39B
  • Volume
    1,784,486
  • Sector
    Health
  • 52W High
    $30.57
  • 52W Low
    $19.65
  • Typical Hold Time
    77 Days
  • Enterprise Value
    $2.50B
  • Div Yield
    -
  • Trading Activity
    0% Sell | 100% Buy
$19.39
52W Low: $19.39
09 Oct 2026
52W High: $30.57
25 Aug 2026

Track ACADIA Pharmaceuticals Inc. (ACAD) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, ACADIA Pharmaceuticals Inc. has traded between a low of $19.39 and a high of $30.57, highlighting its annual price range. Buy and sell ACADIA Pharmaceuticals Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!